Epigenetics in inflammatory rheumatic diseases

Arthritis and Rheumatism

Volumn 56, Issue 11, 2007, Pages 3523-3531

  Huber, Lars C ^a   Stanczyk, Joanna ^a   Jüngel, Astrid ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CELL NUCLEUS DNA; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; MESSENGER RNA; MICRORNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACETYLATION; DNA METHYLATION; ENZYME ACTIVE SITE; EPIGENETICS; HUMAN; HUMAN GENOME PROJECT; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN MODIFICATION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RNA METABOLISM; STEREOSPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TRANSCRIPTION REGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; CONNECTIVE TISSUE DISEASES; EPIGENESIS, GENETIC; HUMANS;

EID: 36049022751     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22948     Document Type: Review

References (65)

1. Huber LC, Distler O. Rheumatology related genes: identification. In: Ganten D, Ruckpaul K, editors. Encyclopedic reference of genomics and proteomics in molecular medicine. Berlin, Germany: Springer; 2006. p. 1670-7.
2. Wildman DE. A map of the common chimpanzee genome. Bioessays 2002;24:490-3.
3. Southan C. Has the yo-yo stopped? An assessment of human protein-coding gene number [review]. Proteomics 2004;4:1712-26.
4. Little PF. Structure and function of the human genome. Genome Res 2005;15:1759-66.
5. Farga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005;102:10604-9.
6. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004;8:350-8.
7. Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol 2006;176:7143-7.
8. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89-97.
9. De Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003;370(Pt 3):737-49.
10. Adcock IM, Ford P, Barnes PJ, Ito K. Epigenetics and airways disease. Respir Res 2006;7:1-21.
11. Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators. Trends Genet 2003;19:286-93.
12. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005;25:552-63.
13. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005;363:15-23.
14. Vigushin DM, Coombes RC. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 2002;13:1-13.
15. Zhang B, Wang Q, Pan X. MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 2007;210:279-89.
16. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73.
17. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007;17:118-26.
18. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50.
19. Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
20. Krutzfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 2006;4:9-12.
21. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, et al. A role for dicer in immune regulation. J Exp Med 2006;203:2519-27.
22. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
23. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
24. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007;67:1419-23.
25. Saito Y, Jones PA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006;5:2220-2.
26. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9:435-43.
27. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006;66:1277-81.
28. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006;580:4214-7.
29. Huber LC, Gay RE, Gay S. Synovial activation. In: Falus A, editor. Immunogenomics and human disease. Chichester, UK: John Wiley & Sons; 2006. p. 299-325.
30. Ermann J, Fathman CG. Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol 2001;2:759-61.
31. Smith JB, Haynes MK. Rheumatoid arthritis: a molecular understanding. Ann Intern Med 2002;136:908-22.
32. Schwab J, Illges H. Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island. Rheumatol Int 2001;20:133-7.
33. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 2000;43:2634-47.
34. Kuchen S, Seemayer CA, Rethage J, von Knoch R, Kucnzler P, Beat AM, et al. The L1 retroelement-related p40 protein induces p38δ MAP kinase. Autoimmunity 2004;37:57-65.
35. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352:1967-76.
36. Huber LC, Brock M, Hemmatazad H, Giger OT, Moritz F, Trenkmann M, et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 2007;56:1087-93.
37. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 2006;203:7-13.
38. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006;45:669-75.
39. Jungel A, Baresova V, Ospelt C, Simmen BR, Michel BA, Gay RE, et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. Ann Rheum Dis 2006;65:910-2.
40. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2003;2:181-91.
41. Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006;54:2271-9.
42. Rombouts K, Niki T, Wielant A, Hcllemans K, Geerts A. Trichostatin A, lead compound for development of antifibrogenic drugs. Acta Gastroenterol Belg 2001;64:239-46.
43. 1induced fibrogenesis in skin fibroblasts. Exp Cell Res 2002;278:184-97.
44. Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 1999;29:858-67.
45. Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA, et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 2007;56:2755-64.
46. Ghosh AK, Mori Y, Dowling E, Varga J. Trichostatin A blocks TGF-β-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007;354:420-6.
47. Simonsson M, Heldin CH, Ericsson J, Gronroos E. The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem 2005;280:21797-803.
48. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178-91.
49. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005;4:189-94.
50. Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, Kalden JR, et al. SLE: a disease of clearance deficiency? Rheumatology (Oxford) 2005;44:1101-7.
51. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
52. Huber LC, Gay S, Distler O, Pisetsky DS. The effect of UVB on lupus skin: new light on the role of apoptosis in the pathogenesis of autoimmunity. Rheumatology (Oxford) 2006;45:500-1.
53. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990;33:1665-73.
54. Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001;44:397-407.
55. Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 2006;5:449-67.
56. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003;109:72-9.
57. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995;154:3025-35.
58. Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, et al. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol 2006;176:2095-104.
59. Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S, et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004;50:1850-60.
60. Lu Q, Tesmer L, Wu A, Ray D, Richardson B. Women and lupus: the inactive X awakens [abstract]. Arthritis Rheum 2006;54 Suppl 9:S775.
61. Mishra N, Brown DR, Olorenshaw IM, Kammer GM. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-γ gene and protein expression in lupus T cells. Proc Natl Acad Sci U S A 2001;98:2628-33.
62. Jones PA, Martienssen R. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 2005;65:11241-6.
63. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat Res 2006;600:46-57.
64. Januchowski R, Dabrowski M, Ofori H, Jagodzinski PP. Trichostatin A down-regulates DNA methyltransferase 1 in Jurkat T cells. Cancer Lett 2006;246:313-7.
65. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004;229:988-95.